1 – 8 of 8
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Hypoxia-induced complement component 3 promotes aggressive tumor growth in the glioblastoma microenvironment
(
- Contribution to journal › Article
- 2021
-
Mark
Evaluation of the Sialidase Inhibitor Oseltamivir in GNE-associated Thrombocytopenia
2021) The XXIX Congress of the International Society on Thrombosis and Haemostasis (ISTH) In Research and practice in thrombosis and haemostasis 5(S2). p.644-645(
- Contribution to journal › Published meeting abstract
-
Mark
Severe Congenital Thrombocytopenia Characterized by Decreased Platelet Sialylation and Moderate Complement Activation Caused by Novel Compound Heterozygous Variants in GNE
(
- Contribution to journal › Article
-
Mark
Cancer and autoimmunity: two sides of the same coin. Complement system proteins in the regulation of immune responses.
2021) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
- 2020
-
Mark
Complement inhibitor factor H expressed by breast cancer cells differentiates CD14+ human monocytes into immunosuppressive macrophages
(
- Contribution to journal › Article
- 2017
-
Mark
Plasma C4d as marker for lupus nephritis in systemic lupus erythematosus
(
- Contribution to journal › Article
- 2016
-
Mark
Factor H uptake regulates intracellular C3 activation during apoptosis and decreases the inflammatory potential of nucleosomes.
(
- Contribution to journal › Article
- 2015
-
Mark
Oxidant-based anticancer activity of a novel synthetic analogue of capsaicin, capsaicin epoxide
(
- Contribution to journal › Article